Tang KJ - Search Results

1

Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer.

Xie Z, Wang Y, Chen T, Fan W, Wei L, Liu B, Situ X, Zhan Q, Fu T, Tian T, Li S, He Q, Zhou J, Wang H, Du J, Tseng HR, Lei Y, Tang KJ, Ke Z. Xie Z, et al. Among authors: tang kj. Drug Resist Updat. 2024 Sep;76:101117. doi: 10.1016/j.drup.2024.101117. Epub 2024 Jul 2. Drug Resist Updat. 2024. PMID: 38996549

2

Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study.

Cui Y, Fang W, Li C, Tang K, Zhang J, Lei Y, He W, Peng S, Kuang M, Zhang H, Chen L, Xu D, Tang C, Zhang W, Zhu Y, Jiang W, Jiang N, Sun Y, Chen Y, Wang H, Lai Y, Li S, He Q, Zhou J, Zhang Y, Lin M, Chen H, Zhou C, Wang C, Wang J, Zou X, Wang L, Ke Z. Cui Y, et al. Clin Cancer Res. 2019 Mar 1;25(5):1546-1556. doi: 10.1158/1078-0432.CCR-18-2545. Epub 2018 Nov 2. Clin Cancer Res. 2019. PMID: 30389658

3

Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib.

Tang K, Jiang N, Kuang Y, He Q, Li S, Luo J, Jiang W, Chen Y, Sun Y, Chen L, Chen Y, Zhu J, Cui Y, Wan H, Ke Z. Tang K, et al. Thorac Cancer. 2019 Feb;10(2):359-364. doi: 10.1111/1759-7714.12927. Epub 2018 Dec 6. Thorac Cancer. 2019. PMID: 30521113 Free PMC article.

4

High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients.

Chen Y, Sun Y, Cui Y, Lei Y, Jiang N, Jiang W, Wang H, Chen L, Luo J, Chen Y, Tang K, Zhou C, Ke Z. Chen Y, et al. Cancer Cell Int. 2019 Nov 29;19:318. doi: 10.1186/s12935-019-1041-5. eCollection 2019. Cancer Cell Int. 2019. PMID: 31798347 Free PMC article.

5

Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells Using Aptamer Cocktail-Modified Nanosubstrates.

Zhu Y, Zou C, Zhang J, Jiang W, Guan F, Tang K, Li S, Li G, Wang J, Ke Z. Zhu Y, et al. ACS Appl Mater Interfaces. 2020 Feb 5;12(5):5671-5679. doi: 10.1021/acsami.9b22234. Epub 2020 Jan 27. ACS Appl Mater Interfaces. 2020. PMID: 31940177

6

Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma).

Sun Y, Luo J, Chen Y, Cui J, Lei Y, Cui Y, Jiang N, Jiang W, Chen L, Chen Y, Kuang Y, Tang K, Ke Z. Sun Y, et al. Int Immunopharmacol. 2020 Mar;80:106198. doi: 10.1016/j.intimp.2020.106198. Epub 2020 Jan 15. Int Immunopharmacol. 2020. PMID: 31954274 Free article.

7

HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.

Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei Y, Tang K, Sun Y, Zhang W, Li S, He Q, Zhou J, Chen Y, Luo J, Jiang W, Ke Z. Jiang N, et al. Theranostics. 2020 Jan 22;10(6):2553-2570. doi: 10.7150/thno.41120. eCollection 2020. Theranostics. 2020. PMID: 32194819 Free PMC article.

8

Correction to "Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells using Aptamer Cocktail-Modified Nanosubstrates".

Zhu Y, Zou C, Zhang J, Jiang W, Guan F, Tang K, Li S, Li G, Wang J, Ke Z. Zhu Y, et al. ACS Appl Mater Interfaces. 2020 Apr 1;12(13):15952. doi: 10.1021/acsami.0c04918. Epub 2020 Mar 23. ACS Appl Mater Interfaces. 2020. PMID: 32202751 No abstract available.

9

A CT-derived deep neural network predicts for programmed death ligand-1 expression status in advanced lung adenocarcinomas.

Zhu Y, Liu YL, Feng Y, Yang XY, Zhang J, Chang DD, Wu X, Tian X, Tang KJ, Xie CM, Guo YB, Feng ST, Ke ZF. Zhu Y, et al. Among authors: tang kj. Ann Transl Med. 2020 Aug;8(15):930. doi: 10.21037/atm-19-4690. Ann Transl Med. 2020. PMID: 32953730 Free PMC article.

10

Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC.

Kuang Y, Xu P, Wang J, Zheng Y, Sun X, Li Z, Gan R, Li H, Guo Y, Yao F, Zhu C, Ke Z, Tang K. Kuang Y, et al. Mol Diagn Ther. 2021 Jul;25(4):487-494. doi: 10.1007/s40291-021-00532-8. Epub 2021 Jun 16. Mol Diagn Ther. 2021. PMID: 34133003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters